Mounjaro (tirzepatide) Approval Letter

FDA approved Mounjaro (tirzepatide) injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Not legal or medical advice.

This page is for informational purposes only. Always verify the current official source or consult a qualified professional before making compliance, prescribing, purchasing, or clinical decisions. Read full disclaimer.

U.S. Food and Drug AdministrationApproval letterApproved
Docket / Citation
NDA 215866
Published
2022-05-13
Effective
2022-05-13